CLOs on the Move

United Therapeutics

www.unither.com

 
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. We currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! Our employees can be found collaborating across the United States, Europe and Asia. As a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases.
  • Number of Employees: 250-1000
  • Annual Revenue: $500M-1 Billion
  • www.unither.com
  • 1040 Spring Street
    Silver Spring, MD USA 20910
  • Phone: 877.864.8437

Executives

Name Title Contact Details
Sam Mancuso
Vice President, Global Quality Systems and Compliance Profile
Vicky Ames
Director, Information Security, Risk and Compliance Profile
Shaun Snader
Vice President and Associate General Counsel, Intellectual Property Profile
John Hess
Executive Vice President, Deputy General Counsel and Assistant Corporate Secretary Profile
Dieter Peise
Senior Director, Corporate Compliance Profile

Similar Companies

Bio Corporation

Bio Corporation is a Alexandria, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pyxant Labs

Pyxant Labs is a Colorado Springs, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Behavioral Health Sciences Institute

Behavioral Health Sciences Institute is a Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hospice of Queen Annes

Hospice of Queen Annes is a Stevensville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome`s natural roles in promoting health.